Aldeyra Therapeutics Ownership | Who Owns Aldeyra Therapeutics?


OverviewForecastRevenueFinancialsChart

Aldeyra Therapeutics Ownership Summary


Aldeyra Therapeutics is owned by 61.65% institutional investors, 2.44% insiders, and 35.91% retail investors. Perceptive advisors is the largest institutional shareholder, holding 15.61% of ALDX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.95% of its assets in Aldeyra Therapeutics shares.

ALDX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAldeyra Therapeutics61.65%2.44%35.91%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Perceptive advisors9.28M15.61%$30.70M
Knoll capital management5.48M9.22%$18.12M
Vanguard group3.74M6.30%$12.39M
Blackrock3.62M6.10%$11.99M
Kennedy capital management1.60M2.69%$5.29M
Geode capital management1.14M1.92%$3.77M
State street957.72K1.61%$3.17M
Eagle asset management841.57K1.42%$2.74M
Dimensional fund advisors lp672.06K1.13%$2.22M
Federated hermes531.22K0.89%$1.76M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Knoll capital management5.48M12.21%$18.12M
Perceptive advisors9.28M0.73%$30.70M
Kennedy capital management1.60M0.11%$5.29M
Pfg investments396.25K0.09%$1.31M
Palo alto investors lp225.47K0.09%$746.29K
Providence wealth advisors25.00K0.07%$84.00K
Joseph p. lucia & associates28.25K0.05%$93.51K
Laidlaw wealth management16.88K0.03%$55.86K
International assets investment management57.80K0.02%$191.32K
Tobias financial advisors23.70K0.02%$78.43K

Top Buyers

HolderShares% AssetsChange
Perceptive advisors9.28M0.73%682.26K
Federated hermes531.22K0.00%531.22K
Pfg investments396.25K0.09%396.25K
Blackrock3.62M0.00%311.16K
Kennedy capital management1.60M0.11%281.52K

Top Sellers

HolderShares% AssetsChange
Verition fund management219.83K0.00%-720.57K
Millennium management43.83K0.00%-344.88K
Johnson & johnson---299.67K
D. e. shaw321.94K0.00%-225.70K
Renaissance503.30K0.00%-224.39K

New Positions

HolderShares% AssetsChangeValue
Pfg investments396.25K0.09%396.25K$1.31M
Panagora asset management60.30K0.00%60.30K$199.59K
Cibc private wealth group51.46K0.00%51.46K$170.33K
Alps advisors46.33K0.00%46.33K$153.34K
Corebridge financial26.80K0.00%26.80K$88.72K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-9.00
Innealta capital-46.00
Metropolitan life insurance co/ny-197.00
Truvestments capital-265.00
Lindbrook capital-544.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241179.35%36,698,4923.87%611.74%6013.21%24-22.58%
Jun 30, 2024105-0.94%35,151,111-0.76%591.64%5110.87%31-6.06%
Mar 31, 2024106-2.75%35,421,6540.85%601.70%46-33-28.26%
Dec 31, 2023109-13.49%35,123,488-7.02%591.44%46-13.21%4615.00%
Sep 30, 2023126-4.55%37,775,100-3.23%641.46%53-28.38%4042.86%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.76M2.95%-
iShares Russell 2000 ETF1.30M2.18%-2.91K
Kennedy Micro Cap859.51K1.45%-273.37K
Vanguard Institutional Extnd Mkt Idx Tr697.57K1.17%-
Vanguard Explorer Inv680.00K1.14%-
Invesco Dorsey Wright SmallCap Momt ETF634.12K1.07%-
Fidelity Small Cap Index510.13K0.86%-9.97K
iShares Russell 2000 Value ETF415.31K0.70%-
Eagle Small Cap Growth – Institutional376.02K0.63%-83.48K
State St Russell Sm/Mid Cp® Indx NL Cl C325.10K0.55%-10.20K

Recent Insider Transactions


DateNameRoleActivityValue
May 03, 2021Miller-Rich Nancy-Buy$5.29K
Apr 12, 2023Miller-Rich Nancy-Buy$5.16K
Aug 12, 2024Machatha Stephen Chief Development OfficerSell$75.97K
Aug 12, 2024Greenberg Bruce See RemarksSell$51.31K
Mar 12, 2024Machatha Stephen Chief Development OfficerSell$36.50K

Insider Transactions Trends


DateBuySell
2024 Q3-2
2024 Q25-
2024 Q1-7
2023 Q4-2
2023 Q3--

ALDX Ownership FAQ


Who Owns Aldeyra Therapeutics?

Aldeyra Therapeutics shareholders are primarily institutional investors at 61.65%, followed by 2.44% insiders and 35.91% retail investors. The average institutional ownership in Aldeyra Therapeutics's industry, Biotech Stocks , is 47.04%, which Aldeyra Therapeutics exceeds.

Who owns the most shares of Aldeyra Therapeutics?

Aldeyra Therapeutics’s largest shareholders are Perceptive advisors (9.28M shares, 15.61%), Knoll capital management (5.48M shares, 9.22%), and Vanguard group (3.74M shares, 6.30%). Together, they hold 31.13% of Aldeyra Therapeutics’s total shares outstanding.

Does Blackrock own Aldeyra Therapeutics?

Yes, BlackRock owns 6.10% of Aldeyra Therapeutics, totaling 3.62M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.99M$. In the last quarter, BlackRock increased its holdings by 311.16K shares, a 9.40% change.

Who is Aldeyra Therapeutics’s biggest shareholder by percentage of total assets invested?

Knoll capital management is Aldeyra Therapeutics’s biggest shareholder by percentage of total assets invested, with 12.21% of its assets in 5.48M Aldeyra Therapeutics shares, valued at 18.12M$.

Who is the top mutual fund holder of Aldeyra Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aldeyra Therapeutics shares, with 2.95% of its total shares outstanding invested in 1.76M Aldeyra Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools